Sedana Medical is a pioneering medtech and pharmaceutical brand that focuses on inhaled sedation to enhance the lives of patients during and after sedation. Their innovative medical device, Sedaconda ACD, combined with the pharmaceutical product, Sedaconda (isoflurane), provides inhaled sedation for patients in intensive care who are on mechanical ventilation. With a presence in Benelux, France, Germany, Great Britain, the Nordic countries, and Spain, Sedana Medical directly sells its products.

In other parts of Europe, Asia, Australia, Canada, and South and Central America, the company collaborates with external distributors. Founded in 2005, Sedana Medical is listed on Nasdaq Stockholm and has its headquarters in Stockholm, Sweden. With approximately 100 employees representing 16 nationalities, Sedana Medical has achieved total sales of MSEK 159 in 2021 across more than 40 countries.

The company values exploration, collaboration, and trust, which contribute to their culture and daily work. Sedana Medical follows ISO 13485 standards for medical device design and manufacturing and holds MDSAP certificates for Canada and Japan. They continuously strive for excellence in their product development and manufacturing processes.

For further information about their products, research, career opportunities, or general inquiries, you can reach Sedana Medical at their head office in Danderyd, Sweden. They can be contacted via phone at +46 8 124 05 200 or email at info@sedanamedical. com